SUMO2 and neoplasm: Analyzing different tumor subsets, central chondrosarcoma and peripheral chondrosarcoma, separately showed that high SUMO2/3 expression significantly decreased overall survival in peripheral chondrosarcoma (p = 0.0298) (Figure S1).